The UK Regenerative Medicine Platform (UKRMP) is a £25M initiative that is addressing the key translational challenges of regenerative medicine. Established in 2013 by the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC) and the Medical Research Council (MRC), the UKRMP provides critical mass of academic expertise, innovation and knowledge, connected to commercial and clinical end-users.
Central to the Platform are five interdisciplinary and complementary research Hubs that collectively provide a national resource through the generation of new tools, protocols and resources that can be utilised by other UK research groups in both academia and industry. The Hubs draw together the major players in UK regenerative medicine research in a dynamic relationship that is outward facing and open to new partnerships.
The five Hubs are (follow links for further details):
Theme 5: Immunomodulation Hub
In addition to the Hubs, five clinically focused research projects were initiated in 2014 through the UKRMP, which link to or exploit aspects of the science being progressed through the Hubs.
The Platform provides a cornerstone of the broader and integrated UK research strategy in this area, which is seeking to support high quality UK research activity and translational activity that will help deliver the great promise of regenerative medicine to the benefit of both patients and future economic growth.
The 2015 Annual Report of the UKRMP is available through the link here.
Friday, March 31, 2017
The UK Regenerative Medicine Platform (UKRMP), is to receive a further multimillion funding commitment to help realise the goal of […]More »
Thursday, March 23, 2017
The sponsors of the UK Regenerative Medicine Platform (UKRMP), the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC) […]More »
Monday, March 6, 2017
Research teams based at the Universities of Dundee and Edinburgh are looking to partner with the pharmaceutical industry to better […]More »